132 related articles for article (PubMed ID: 20605240)
21. Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries.
Tanimoto S; Daemen J; Tsuchida K; García-García HM; de Jaegere P; van Domburg RT; Serruys PW
Catheter Cardiovasc Interv; 2007 Jan; 69(1):94-103. PubMed ID: 17139687
[TBL] [Abstract][Full Text] [Related]
22. Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: the Korean Multicenter Angioplasty Team (KOMATE) Registry.
Kim JS; Lee BH; Ko YG; Choi D; Jang Y; Min PK; Yoon YW; Hong BK; Kwon HM; Ahn MS; Lee SH; Yoon JH; Lee BK; Kim BO; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Jung JH; Ryu SK;
Catheter Cardiovasc Interv; 2008 Nov; 72(5):601-7. PubMed ID: 18942123
[TBL] [Abstract][Full Text] [Related]
23. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
24. Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registry.
Bucalo R; Capranzano P; Conti G; Capodanno D; Ruperto C; Blundo A; Caggegi A; Tamburino C; Sanfilippo A; Tamburino C
J Cardiovasc Med (Hagerstown); 2010 May; 11(5):365-8. PubMed ID: 20150821
[TBL] [Abstract][Full Text] [Related]
25. Sirolimus- versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis.
Lee SH; Ko YG; Jang Y; Kwon HM; Lee SH; Yoon JH; Park SH; Kim BO; Jeon DW; Yang JY; Ryu SK;
Cardiology; 2005; 104(4):181-5. PubMed ID: 16155390
[TBL] [Abstract][Full Text] [Related]
26. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
[TBL] [Abstract][Full Text] [Related]
29. Outlook of drug-eluting stent implantation for unprotected left main disease: insights on long-term clinical predictors.
Vecchio S; Chechi T; Vittori G; Biondi Zoccai GG; Lilli A; Spaziani G; Giuliani G; Falchetti E; Margheri M
J Invasive Cardiol; 2007 Sep; 19(9):381-7. PubMed ID: 17827507
[TBL] [Abstract][Full Text] [Related]
30. One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries.
Rodriguez-Granillo GA; Valgimigli M; Garcia-Garcia HM; Ong AT; Aoki J; van Mieghem CA; Tsuchida K; Sianos G; McFadden E; van der Giessen WJ; van Domburg R; de Feyter P; Serruys PW
J Invasive Cardiol; 2005 Aug; 17(8):409-12. PubMed ID: 16079445
[TBL] [Abstract][Full Text] [Related]
31. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
Kim JW; Suh SY; Choi CU; Na JO; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ
JACC Cardiovasc Interv; 2008 Feb; 1(1):65-71. PubMed ID: 19393147
[TBL] [Abstract][Full Text] [Related]
32. Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.
Kim MH; Hong SJ; Cha KS; Park HS; Chae SC; Hur SH; Gwon HC; Bae JH; Lim DS
J Interv Cardiol; 2008 Jun; 21(3):225-31. PubMed ID: 18341520
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions.
Park KH; Park SW; Hong MK; Kim YH; Lee BK; Park DW; Choi BR; Kim MJ; Park KM; Lee CW; Cheong SS; Kim JJ; Park SJ
Catheter Cardiovasc Interv; 2006 Apr; 67(4):589-94. PubMed ID: 16547937
[TBL] [Abstract][Full Text] [Related]
34. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry.
Trabattoni D; Fabbiocchi F; Montorsi P; Ravagnani P; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
Catheter Cardiovasc Interv; 2007 Sep; 70(3):415-21. PubMed ID: 17722020
[TBL] [Abstract][Full Text] [Related]
35. Impact of diabetes mellitus on the treatment effect of percutaneous or surgical revascularization for patients with unprotected left main coronary artery disease: a subgroup analysis of the MAIN-COMPARE study.
Kim WJ; Park DW; Yun SC; Lee JY; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2009 Oct; 2(10):956-63. PubMed ID: 19850255
[TBL] [Abstract][Full Text] [Related]
36. Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study.
Biondi-Zoccai GG; Sangiorgi GM; Antoniucci D; Grube E; Di Mario C; Reimers B; Tamburino C; Agostoni P; Cosgrave J; Colombo A;
Int J Cardiol; 2007 May; 117(3):349-54. PubMed ID: 16859781
[TBL] [Abstract][Full Text] [Related]
37. Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry.
Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Neumann FJ; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Richardt G;
Heart; 2007 Oct; 93(10):1251-5. PubMed ID: 17890701
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
Cosgrave J; Agostoni P; Ge L; Iakovou I; Chieffo A; Biondi-Zoccai GG; Sangiorgi GM; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Bonizzoni E; Colombo A
Am J Cardiol; 2005 Dec; 96(12):1663-8. PubMed ID: 16360354
[TBL] [Abstract][Full Text] [Related]
39. Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).
Cherradi R; Ouldzein H; Zouaoui W; Elbaz M; Puel J; Carrié D
Arch Cardiovasc Dis; 2008 Jan; 101(1):11-7. PubMed ID: 18391867
[TBL] [Abstract][Full Text] [Related]
40. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.
Daemen J; Wenaweser P; Tsuchida K; Abrecht L; Vaina S; Morger C; Kukreja N; Jüni P; Sianos G; Hellige G; van Domburg RT; Hess OM; Boersma E; Meier B; Windecker S; Serruys PW
Lancet; 2007 Feb; 369(9562):667-78. PubMed ID: 17321312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
